Potential involvement of GRIN2B encoding the NMDA receptor subunit NR2B in the spectrum of Alzheimer's disease

Journal of Neural Transmission

Volumn 121, Issue 5, 2014, Pages 533-542

  Andreoli, Virginia ^a   De Marco, Elvira Valeria ^a   Trecroci, Francesca ^a   Cittadella, Rita ^a   Di Palma, Gemma ^a   Gambardella, Antonio ^a,b  

^a INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Alzheimer's dementia; Excitotoxicity; Glutamate; N methyl d aspartate receptors GRIN2B gene; Regulation of synaptogenesis

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; APOLIPOPROTEIN E4; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NR2B NMDA RECEPTOR;

AGED; ALLELE; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA FLANKING REGION; EXON; FEMALE; GENETIC CODE; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; MINI MENTAL STATE EXAMINATION; MISSENSE MUTATION; PATHOGENESIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; AGE; CAUCASIAN; GENETIC PREDISPOSITION; GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; SEX DIFFERENCE;

AGE FACTORS; AGED; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; DNA MUTATIONAL ANALYSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; ITALY; MALE; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, N-METHYL-D-ASPARTATE; SEX FACTORS;

EID: 84901306605     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-013-1125-7     Document Type: Article

References (46)

1. Andreoli V, Trecroci F, La Russa A, Cittadella R, Liguori M, Spadafora P, Caracciolo M, Di Palma G, Colica C, Gambardella A, Quattrone A (2011) Presenilin enhancer-2 gene: identification of a novel promoter mutation in a patient with early-onset familial Alzheimer's disease. Alzheimers Dement 7(6):574-578. doi:0.1016/.jalz.2011.2.010
2. Beste C, Baune BT, Domschke K, Falkenstein M, Konrad C (2010) Dissociable influences of NR2B-receptor related neural transmission on functions of distinct associative basal ganglia circuits. Neuroimage 52(1):309-315. doi:0.1016/.neuroimage.010.4.22
3. Bi H, Sze CI (2002) N-methyl-D-aspartate receptor subunit NR2A and NR2B messenger RNA levels are altered in the hippocampus and entorhinal cortex in Alzheimer's disease. J Neurol Sci 200(1-2):11-18. doi:0.1016/S0022-510X
4. Cacabelos R (2008) Pharmacogenomics in Alzheimer's disease. Methods Mol Biol 448:213-357. doi:10.1007/978-1-59745-205-2-10
5. Chamary JV, Hurst LD (2005) Evidence for selection on synonymous mutations affecting stability of mRNA secondary structure in mammals. Genome Biol 6(9):R75. doi:10.1186/gb-2005-6-9-r75
6. Chamary JV, Hurst LD (2009) The price of silent mutations. Sci Am 300(6):46-53
7. Chen C, Li X, Wang T, Wang HH, Fu Y, Zhang L, Xiao SF (2010) Association between NMDA receptor subunit 2b gene polymorphism and Alzheimer's disease in Chinese Han population in Shanghai. Neurosci Bull 26(5):395-400. doi:10.1007/s12264-010-0729-2
8. Crum RM, Anthony JC, Bassett SS, Folstein M (1993) Population-based norms for the Mini- Mental State Examination by age and educational level. JAMA 269(18):2386-2391. doi:10.1001/jama.1993.03500180078038 (Pubitemid 23129378)
9. Cruts M, van Duijin CM, Backhovens H, Van den Broeck M, Wehnert A, Serneels S, Sherrington R, Hutton M, Hardy J, St George-Hyslop PH, Hofman A, Van Broeckhoven C (1998) Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Hum Mol Genet 7(1):43-51. doi:10.1093/hmg/7.1.43 (Pubitemid 28040736)
10. Cull-Candy SG, Leszkiewicz DN (2004) Role of distinct NMDA receptor subtypes at central synapses. Sci STKE 2004(255):re16
11. Danysz W, Parsons CG (2012) Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine - searching for the connections. Br J Pharmacol 67(2):324-352. doi:10.1111/j.1476-5381.2012.02057
12. Darreh-Shori T, Siawesh M, Mousavi M, Andreasen N, Nordberg A (2012) Apolipoprotein ε4 modulates phenotype of butyrylcholinesterase in CSF of patients with Alzheimer's disease. J Alzheimers Dis 28(2):443-458. doi:10.3233/JAD-2011-111088
13. Dorval KM, Wigg KG, Crosbie J, Tannock R, Kennedy JL, Ickowicz A, Pathare T, Malone M, Schachar R, Barr CL (2007) Association of the glutamate receptor subunit gene GRIN2B with attention-deficit/hyperactivity disorder. Genes Brain Behav 6(5):444-452. doi:10.1111/j.1601-183X.2006.00273.x (Pubitemid 47024958)
14. Endele S, Rosenberger G, Geider K, Popp B, Tamer C, Stefanova I, Milh M, Kortüm F, Fritsch A, Pientka FK, Hellenbroich Y, Kalscheuer VM, Kohlhase J, Moog U, Rappold G, Rauch A, Ropers HH, von Spiczak S, Tönnies H, Villeneuve N, Villard L, Zabel B, Zenker M, Laube B, Reis A, Wieczorek D, Van Maldergem L, Kutsche K (2010) Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes. Nat Genet 2(11):1021-1026. doi:10.1038/ng.677
15. Frueh FW, Noyer-Weidner M (2003) The use of denaturing high-performance liquid chromatography (DHPLC) for the analysis of genetic variations: impact for diagnostic and pharmacogenetics. Clin Chem Lab Med 41(4):452-461. doi:10.15/CCLM.2003.068 (Pubitemid 36592108)
16. Goate AM, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L et al (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349(6311):704-706. doi:10.1038/349704a0 (Pubitemid 21912142)
17. Guerreiro RJ, Gustafson DR, Hardy J (2012) The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE. Neurobiol Aging 33(3):437-456. doi:10.1016/j.neurobiolaging.2010.03.025
18. Hawkins LM, Prybylowski K, Chang K, Moussan C, Stephenson FA, Wenthold RJ (2004) Export from the endoplasmic reticulum of assembled N-Methyl-D-aspartic Acid receptors is controlled by a motif in the C terminus of the NR2 subunit. J Biol Chem 279(28):28903-28910. doi:10.1074/jbc.M402599200 (Pubitemid 38915758)
19. Hu NW, Ondrejcak T, Rowan MJ (2012) Glutamate receptors in preclinical research on Alzheimer's disease: update on recent advances. Pharmacol Biochem Behav 100(4):855-862. doi:10.1016/j.pbb.2011.04.013
20. Jiang H, Jia J (2009) Association between NR2B subunit gene (GRIN2B) promoter polymorphisms and sporadic Alzheimer's disease in the North Chinese population. Neurosci Lett 450(3):356-360. doi:10.1016/j.neulet.2008.10.075
21. Kutsuwada T, Sakimura K, Manabe T, Takayama C, Katakura N, Kushiya E, Natsume R, Watanabe M, Inoue Y, Yagi T, Aizawa S, Arakawa M, Takahashi T, Nakamura Y, Mori H, Mishina M (1996) Impairment of suckling response, trigeminal neuronal pattern formation, and hippocampal LTD in NMDA receptor epsilon 2 subunit mutant mice. Neuron 16(2):333-344. doi:10.1016/S0896-6273(00)80051-3
22. Lau CG, Zukin RS (2007) NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci 8(6):413-426. doi:10.1038/nrn2153 (Pubitemid 46789232)
23. Laube B, Hirai H, Sturgess M, Betz H, Kuhse J (1997) Molecular determinants of agonist discrimination by NMDA receptor subunits: analysis of the glutamate binding site on the NR2B subunit. Neuron 18(3):493-503. doi:10.1016/S0896-6273(00)81249-0 (Pubitemid 27138796)
24. Lleó A, Castellví M, Blesa R, Oliva R (2002) Uncommon polymorphism in the presenilin genes in familial Alzheimer's disease: not to be mistaken as a pathogenic mutation. Neurosci Lett 318(3):166-168. doi:10.1016/S0304-3940(01)02499-5 (Pubitemid 34136035)
25. Luo L, Zhu Y, Xiong M (2012) A novel genome-information content-based statistic for genome-wide association analysis designed for next-generation sequencing data. J Comput Biol 19(6):731-744. doi:10.1089/cmb.2012.0035
26. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34(7):939-944 (Pubitemid 14076461)
27. Metzler M (2011) Mutations in NMDA receptors influence neurodevelopmental disorders causing epilepsy and intellectual disability. Clin Genet 79(3):219-220. doi:10.1111/j.1399-0004.2010.01610.x
28. Mony L, Kew JN, Gunthorpe MJ, Paoletti P (2009) Allosteric modulators of NR2B- containing NMDA receptors: molecular mechanisms and therapeutic potential. Br J Pharmacol 157(8):1301-1317. doi:10.1111/j.1476-5381.2009.00304.x
29. Monyer H, Sprengel R, Schoepfer R, Herb A, Higuchi M, Lomeli H, Burnashev N, Sakmann B, Seeburg PH (1992) Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256(5060):1217-1221. doi:10.1126/science.256.5060.1217
30. Olney JW, Wozniak DF, Farber NB (1997) Excitotoxic neurodegeneration in Alzheimer disease: new hypothesis and new therapeutic strategies. Arch Neurol 4(10):1234-1240. doi:10.1001/archneur.1997.00550220042012 (Pubitemid 27452238)
31. Paoletti P (2011) Molecular basis of NMDA receptor functional diversity. Eur J Neurosci 33(8):1351-1365. doi:10.1111/j.1460-9568.2011.07628
32. Petralia RS (2012) Distribution of extrasynaptic NMDA receptors on neurons. Sci World J 2012:267120. doi:10.1100/2012/267120
33. Porsteinsson AP, Grossberg GT, Mintzer J, Olin JT, Memantine MEM-MD-12 Study Group (2008) Memantine treatment in patients) with mild to disease moderate Alzheimer's already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial. Curr Alzheimer Res 5(1):83-89. doi:10.2174/5672058783884576 (Pubitemid 351536358)
34. Reisberg B, Doody R, Stöffler A, Schmitt F, Ferris S, Möbius HJ, Memantine Study Group (2003) Memantine in moderate to-severe Alzheimer's disease. N Engl J Med 348(14):1333-1341. doi:10.1056/NEJMoa013128 (Pubitemid 36384100)
35. Sadigh-Eteghad S, Talebi M, Farhoudi M (2012) Association of apolipoprotein E epsilon 4 allele with sporadic late onset Alzheimer's disease: a meta-analysis. Neurosciences (Riyadh) 17(4):321-326
36. Santangelo RM, Acker TM, Zimmerman SS, Katzman BM, Strong KL, Traynelis SF, Liotta DC (2012) Novel NMDA receptor modulators: an update. Expert Opin Ther Pat 22(11):1337-1352. doi:10.1517/13543776.2012.728587
37. Schito AM, Pizzuti A, Di Maria E, Schenone A, Ratti A, Defferrari R, Bellone E, Mancardi GL, Ajmar F, Mandich P (1997) mRNA distribution in adult human brain of GRIN2B, a N-methyl-D-aspartate (NMDA) receptor subunit. Neurosci Lett 239(1):49-53. doi:0.1016/S0304-3940(97)00853-7
38. Seripa D, Matera MG, Franceschi M, Bizzarro A, Paris F, Cascavilla L, Rinaldi M, Panza F, Solfrizzi V, Daniele A, Masullo C, Dallapiccola B, Pilotto A (2008) Association analysis of GRIN2B, encoding N-methyl-D-aspartate receptor 2B subunit, and Alzheimer's disease. Dement Geriatr Cogn Disord 25(3):287-292. doi:10.1159/000118634 (Pubitemid 351363894)
39. Singh P, Doshi S, Spaethling JM, Hockenberry AJ, Patel TP, Geddes-Klein DM, Lynch DR, Meaney DF (2012) N methyl-D-aspartate receptor mechanosensitivity is governed by C-terminus of NR2B subunit. J Biol Chem 287(6):4348-4359. doi:10.1074/jbc.M111.253740
40. Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, Nairn AC, Salter MW, Lombroso PJ, Gouras GK, Greengard P (2005) Regulation of NMDA receptor trafficking by amyloid-β. Nat Neurosci 8(8):1051-1058. doi:10.1038/nn1503 (Pubitemid 41061516)
41. Sprengel R, Suchanek B, Amico C, Brusa R, Burnashev N, Rozov A, Hvalby O, Jensen V, Paulsen O, Andersen P, Kim JJ, Thompson RF, Sun W, Webster LC, Grant SGN, Eilers J, Konnerth A, Li J, McNamara JO, Seeburg PH (1998) Importance of the intracellular domain of NR2 subunits for NMDA receptor function in vivo. Cell 92(2):279-289. doi:10.1016/S0092-8674(00)80921-6 (Pubitemid 28073050)
42. Stein JL, Hua X, Morra JH, Lee S, Hibar DP, Ho AJ, Leow AD, Toga AW, Sul JH, Kang HM, Eskin E, Saykin AJ, Shen L, Foroud T, Pankratz N, Huentelman MJ, Craig DW, Gerber JD, Allen AN, Corneveaux JJ, Stephan DA, Webster J, DeChairo BM, Potkin SG, Jack CR Jr, Weiner MW, Thompson PM, Alzheimer's Disease Neuroimaging Initiative (2012) Genome-wide analysis reveals novel genes influencing temporal lobe structure with relevance to neurodegeneration in Alzheimer's disease. Neuroimage 51(2):542-554. doi:10.1016/j.neuroimage.2010.02. 068
43. Sze CI, Bi H, Kleinschmidt-DeMasters BK, Filley CM, Martin LJ (2001) NMDA receptor subunit NR1, NR2A, and NR2B proteins and their phosphorylation status are altered selectively in Alzheimer's disease. J Neurol Sci 175(2):81-90. doi:10.1016/S0022-510X(00)00285-9
44. Tackenberg C, Grinschgl S, Trutzel A, Santuccione AC, Frey MC, Konietzko U, Grimm J, Brandt R, Nitsch RM (2013) NMDA receptor subunit composition determines beta-amyloid-induced neurodegeneration and synaptic loss. Cell Death Dis 25(4):e608. doi:10.1038/cddis.2013.129
45. Winblad B, Jones RW, Wirth Y, Stöffler A, Möbius HJ (2007) Memantine in moderate to severe Alzheimer's disease: a meta-analysis of randomised clinical trials. Dement Geriatr Cogn Disord 24(1):20-27. doi:10.1159/000102568 (Pubitemid 46985287)
46. Yang W, Zheng C, Song Q, Yang X, Qiu S, Liu C, Chen Z, Duan S, Luo J (2007) A three amino acid tail following the TM4 region of the N-methyl-D-aspartate receptor (NR)2 subunits is sufficient to overcome endoplasmic reticulum retention of NR1-1a subunit. J Biol Chem 282(12):9269-9278. doi:10.1074/jbc.M700050200 (Pubitemid 47093485)